DEEP TECH FUNDING ADVISORY

Our clients tackle the most pressing issues of our times.

We find the funding they need to succeed.

We secure institutional capital for breakthrough science.

Applying venture-grade rigour to Europe's most selective public funding instruments. No win, no pay — ever.

Submit your deck

From lab to market.

We navigate the full European venture funding continuum — from early proof-of-concept to large-scale industrial deployment.

DEVELOPMENT

TRL4 to TRL6

Moves early scientific results toward market readiness, bridging the gap between research and commercial viability.

€2,5M Grant

Seed

EIC Transition

MARKET ENTRY

TRL6 to TRL9

EIC Accelerator

€12,5M Grant & Equity

Series A/B

Europe's flagship €10bn venture fund. Combines grant and equity investment for market entry and scale-up activities.

SCALING

Any TRL

€10M - €30M Equity

Series B/C

Step ScaleUp

Equity for industrial deployment and commercial scaling, targeting proven technologies ready for expansion.

EXPANSION

TRL9 +

The European Investment Bank’s large loan facility backing high-growth ventures needing scaling capital while minimising dilution.

€15M to €50M Debt

Series C/D

EIB Venture Debt

Deep Science, Strong Patents.

We partner with exceptional teams, working on high-risk, capital-intensive innovations with defensible intellectual property.

INDUSTRIAL TRANSITION

Alt. Energy Production & Storage, Clean-Tech, Climate-Tech, Novel Foods, Agriculture

STRATEGIC AUTONOMY

New Space & Aeronautics, AI, Quantum Computing, Dual-use, Cyber Security, Semiconductors, Defence

ADVANCING HUMAN HEALTH

Cell & Gene Therapies, Infectious Diseases, Clinical Trials, Drug Development

We assume the risk alongside you.

No upfront fees. No retainers. We are paid only when funding is received — aligning our incentives entirely with your success.

Rigorous Qualification

We review thousands of companies annually and engage only where we identify a credible path to success. We will tell you clearly if we cannot help.

Investor-Grade Preparation

Thousands of hours per mandate: technical validation, financial case building, strategic framing, and hands-on negotiation management.

Industry-wide Recognition

Proven track record. Peer recognition. Founding members of the European Association of Innovation Consultants. Strict adherence to industry standards and to the EIC Code of Conduct.

A selection of ventures we have taken to successful funding.

CERABYTE (DE) - €17,5M

Ceramic based data storage to minimize electronic waste and reduce the energy consumption of data centers worldwide.
WOODOO (FR) - €10,5M

Transforming wood into high-performance alternative to steel, aluminum, and concrete for construction.
BLYKALLA (SWE) - €17,5M

Small nuclear modular reactors for clean energy.
EVEROX (NL) - €12,5M

Everox upcycles concrete waste, replacing raw materials with circular concrete.
ALTRATECH (IE) - €17,5M

Instant portable molecular testing technology.
FIBRIANT (NL) - €16,5M

Recombinant manufacturing of human fibrinogen & thrombin.
CHROMAFORA (SWE) - €22,5M

Filtration technology to remove PFAS and heavy metals from landfills and our water supply.
REVERION (DE) - €12,5M

Reversible high-temperature fuel cells to efficiently convert biogas, hydrogen, or methane into electricity or vice versa
INFINITE ROOTS (DE) - €17,5M

Precision fermentation to develop plant based protein derivatives using mycelium.
GAFT (NL) - €10,5M

End-to-end solution to sustainable aviation fuel from carbon dioxide without fossil fuels.
XENOMATIX (BE) - €8,5M

True solid state LiDAR for autonomous driving
TOPOSENS (DE) - €3,5M

3D Ultrasonic echolocation technology for colision avoidance.
SPHERICAL SYS. (NL) - €4M

Advanced chip architecture for satellite industry applications.
CELLBOX (DE) - €12,5M

Portable CO2 incubator for the transport of biological cells at room temperature.
RNHALE (DE) - €2,5M

Inhalable RNA-based therapeutics.
ESENCIA (DE) - €4,5M

Next-generation alternative protein through precision fermentation.
ECOLYTE (AT) €2,5M

Sustainable energy storage through bio-based electrolytes and paper-derived membranes that replace toxic, mined materials.
FYTEKO (BE) - €2,8M

Biomolecules for plant resiliance and adaptation to the effects of climate change.
LITHOS (AT) - €5,6M

Bio-based pest control solutions, using innovative pheromone technologies to protect crops without harming the environment.